• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Cardiovascular
  • A double blind,double dummy, phase IV, randomized, multicenter, parallel group, placebo control trial to evaluate the effect of rosuvastatin on triglycerides levels in Mexican hypertriglyceridemic patients.

Disease
hypercholesterolaemia
Drug Name
Crestor
Generic Name
rosuvastatin
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
IIIb
Start Date
Nov 21, 2002
Study Name
DC-452-0003
Study Id
DC-452-0003
ClinicalTrials.gov ID
NCT00800800
Recruiting Status
Closed
Protocol Status
Not Available
Report Status
Not Available

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013